- Home
- LBRX vs MNRO Comparison
LBRX vs MNRO Comparison
Compare LBRX & MNRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LBRX | MNRO |
|---|---|---|
| Founded | 2015 | 1957 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Automotive Aftermarket |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 602.6M | 602.5M |
| IPO Year | N/A | 1994 |
Fundamental Metrics
Financial Performance| Metric | LBRX | MNRO |
|---|---|---|
| Price | $23.91 | $17.64 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $49.00 | $17.67 |
| AVG Volume (30 Days) | 181.2K | ★ 650.4K |
| Earning Date | 01-01-0001 | 04-28-2026 |
| Dividend Yield | N/A | ★ 6.09% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.26 |
| Revenue | N/A | ★ $1,195,334,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1.59 |
| P/E Ratio | ★ N/A | $70.54 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $13.40 | $12.20 |
| 52 Week High | $25.60 | $23.91 |
Technical Indicators
Market Signals| Indicator | LBRX | MNRO |
|---|---|---|
| Relative Strength Index (RSI) | 52.85 | 26.73 |
| Support Level | $22.34 | $16.19 |
| Resistance Level | $24.70 | $18.72 |
| Average True Range (ATR) | 1.26 | 0.83 |
| MACD | -0.14 | -0.58 |
| Stochastic Oscillator | 51.76 | 10.13 |
Price Performance
Historical ComparisonAbout LBRX LB Pharmaceuticals Inc
LB Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing novel therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases. It is building a pipeline that leverages the broad therapeutic potential of its lead product candidate, LB-102, which the company believes has the potential to be the first benzamide antipsychotic drug approved for neuropsychiatric disorders in the United States. LB-102 is a new chemical entity and a methylated derivative of amisulpride, a second-generation antipsychotic drug approved in over 50 countries.
About MNRO Monro Inc.
Monro Inc is an operator of retail tire and automotive repair stores in the United States. The company offers replacement tires and tire related services, automotive undercar repair services, and a broad range of routine maintenance services, on passenger cars, light trucks, and vans. It also provides other products and services for brakes; mufflers and exhaust systems; and steering, drive train, suspension, and wheel alignment.